Concepts (261)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units, Neonatal | 24 | 2024 | 336 | 6.050 |
Why?
|
| Infant, Premature | 12 | 2024 | 858 | 2.810 |
Why?
|
| Infant, Premature, Diseases | 7 | 2024 | 255 | 2.110 |
Why?
|
| Infant, Newborn | 53 | 2025 | 8633 | 2.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 9 | 2024 | 83 | 1.610 |
Why?
|
| Infant, Extremely Premature | 8 | 2024 | 106 | 1.590 |
Why?
|
| Noise | 2 | 2023 | 21 | 1.490 |
Why?
|
| Erythropoietin | 6 | 2022 | 110 | 1.330 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2021 | 181 | 1.230 |
Why?
|
| Gestational Age | 13 | 2024 | 1230 | 1.180 |
Why?
|
| Child Development | 3 | 2023 | 286 | 1.050 |
Why?
|
| Lung Diseases | 2 | 2022 | 404 | 1.000 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2021 | 334 | 0.990 |
Why?
|
| Bronchopulmonary Dysplasia | 4 | 2023 | 211 | 0.960 |
Why?
|
| Heart Arrest | 2 | 2021 | 376 | 0.950 |
Why?
|
| Hypothermia, Induced | 6 | 2024 | 169 | 0.940 |
Why?
|
| Lateral Ventricles | 1 | 2025 | 16 | 0.920 |
Why?
|
| Hypoglycemia | 3 | 2021 | 192 | 0.820 |
Why?
|
| Infant | 25 | 2025 | 13257 | 0.790 |
Why?
|
| Pregnancy Complications, Infectious | 3 | 2025 | 496 | 0.770 |
Why?
|
| Anticonvulsants | 2 | 2024 | 394 | 0.760 |
Why?
|
| Tocolytic Agents | 1 | 2022 | 12 | 0.750 |
Why?
|
| Needs Assessment | 1 | 2023 | 181 | 0.740 |
Why?
|
| Brain Diseases | 1 | 2025 | 310 | 0.740 |
Why?
|
| Phenobarbital | 1 | 2021 | 35 | 0.730 |
Why?
|
| Parents | 4 | 2021 | 1073 | 0.710 |
Why?
|
| Incubators, Infant | 1 | 2020 | 4 | 0.680 |
Why?
|
| Visitors to Patients | 1 | 2020 | 9 | 0.680 |
Why?
|
| Papaver | 1 | 2020 | 4 | 0.680 |
Why?
|
| Hospital Administration | 1 | 2020 | 25 | 0.670 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2023 | 203 | 0.670 |
Why?
|
| Neonatal Abstinence Syndrome | 1 | 2020 | 20 | 0.660 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.650 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 59 | 0.640 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 61 | 0.630 |
Why?
|
| Neuroprotection | 1 | 2019 | 32 | 0.630 |
Why?
|
| Infection Control | 1 | 2020 | 161 | 0.610 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2019 | 42 | 0.600 |
Why?
|
| Hypernatremia | 1 | 2019 | 32 | 0.590 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2022 | 378 | 0.580 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 254 | 0.580 |
Why?
|
| Humans | 55 | 2025 | 133529 | 0.570 |
Why?
|
| Hyponatremia | 1 | 2019 | 75 | 0.570 |
Why?
|
| Epoprostenol | 1 | 2018 | 70 | 0.560 |
Why?
|
| Infant, Low Birth Weight | 4 | 2025 | 176 | 0.560 |
Why?
|
| Sodium | 1 | 2019 | 302 | 0.550 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 162 | 0.550 |
Why?
|
| United States | 13 | 2025 | 11761 | 0.540 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2018 | 90 | 0.530 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 208 | 0.520 |
Why?
|
| Betacoronavirus | 1 | 2020 | 305 | 0.520 |
Why?
|
| Nitric Oxide | 2 | 2018 | 483 | 0.480 |
Why?
|
| Retrospective Studies | 14 | 2024 | 17579 | 0.470 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 636 | 0.470 |
Why?
|
| Resuscitation | 1 | 2017 | 268 | 0.460 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 384 | 0.460 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 395 | 0.460 |
Why?
|
| Mass Screening | 1 | 2020 | 833 | 0.440 |
Why?
|
| Hemorrhage | 1 | 2018 | 517 | 0.430 |
Why?
|
| Pregnancy | 11 | 2025 | 7598 | 0.420 |
Why?
|
| Neonatology | 2 | 2025 | 57 | 0.420 |
Why?
|
| Female | 29 | 2025 | 71560 | 0.400 |
Why?
|
| Hypothermia | 2 | 2023 | 64 | 0.390 |
Why?
|
| Pandemics | 1 | 2020 | 1195 | 0.390 |
Why?
|
| Cross-Sectional Studies | 7 | 2024 | 3758 | 0.380 |
Why?
|
| Milk, Human | 3 | 2021 | 311 | 0.380 |
Why?
|
| Typhoid Fever | 1 | 2011 | 19 | 0.360 |
Why?
|
| Salmonella typhi | 1 | 2011 | 21 | 0.360 |
Why?
|
| Retinopathy of Prematurity | 2 | 2024 | 64 | 0.350 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 3990 | 0.340 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 151 | 0.330 |
Why?
|
| Texas | 3 | 2025 | 3668 | 0.300 |
Why?
|
| Male | 21 | 2025 | 65657 | 0.290 |
Why?
|
| Dietary Supplements | 4 | 2024 | 485 | 0.280 |
Why?
|
| Prevalence | 3 | 2025 | 2678 | 0.270 |
Why?
|
| Premature Birth | 2 | 2022 | 417 | 0.250 |
Why?
|
| Patient Selection | 2 | 2021 | 732 | 0.240 |
Why?
|
| Cerebral Palsy | 2 | 2024 | 85 | 0.240 |
Why?
|
| Neonatologists | 1 | 2025 | 20 | 0.230 |
Why?
|
| Decision Making | 2 | 2021 | 702 | 0.220 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2025 | 84 | 0.220 |
Why?
|
| Electroencephalography | 3 | 2024 | 907 | 0.220 |
Why?
|
| Delphi Technique | 1 | 2025 | 241 | 0.210 |
Why?
|
| Incubators | 1 | 2023 | 2 | 0.210 |
Why?
|
| Seizures | 3 | 2024 | 900 | 0.210 |
Why?
|
| Sound | 1 | 2023 | 22 | 0.210 |
Why?
|
| Vitamin D Deficiency | 1 | 2024 | 76 | 0.210 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2024 | 94 | 0.200 |
Why?
|
| Birth Weight | 3 | 2022 | 355 | 0.200 |
Why?
|
| Weight Gain | 2 | 2023 | 412 | 0.200 |
Why?
|
| Oximetry | 1 | 2024 | 178 | 0.200 |
Why?
|
| Vitamin D | 1 | 2024 | 181 | 0.200 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2009 | 405 | 0.190 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2002 | 39 | 0.190 |
Why?
|
| Palivizumab | 1 | 2022 | 48 | 0.190 |
Why?
|
| Tocolysis | 1 | 2022 | 5 | 0.190 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 107 | 0.190 |
Why?
|
| Mothers | 1 | 2025 | 373 | 0.190 |
Why?
|
| Status Epilepticus | 1 | 2023 | 156 | 0.180 |
Why?
|
| Administration, Intravenous | 2 | 2022 | 162 | 0.180 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2022 | 77 | 0.180 |
Why?
|
| Magnesium Sulfate | 1 | 2022 | 51 | 0.180 |
Why?
|
| Consensus | 1 | 2025 | 713 | 0.180 |
Why?
|
| Phenytoin | 1 | 2021 | 63 | 0.180 |
Why?
|
| Refusal to Participate | 1 | 2021 | 3 | 0.180 |
Why?
|
| Breast Feeding | 2 | 2021 | 240 | 0.170 |
Why?
|
| Placenta Diseases | 1 | 2021 | 61 | 0.170 |
Why?
|
| Parental Consent | 1 | 2021 | 22 | 0.170 |
Why?
|
| Patients' Rooms | 1 | 2020 | 10 | 0.170 |
Why?
|
| Hospital Design and Construction | 1 | 2020 | 11 | 0.170 |
Why?
|
| Neuroprotective Agents | 1 | 2022 | 169 | 0.170 |
Why?
|
| Equipment Safety | 1 | 2020 | 36 | 0.170 |
Why?
|
| Tea | 1 | 2020 | 18 | 0.170 |
Why?
|
| Infant Health | 1 | 2020 | 16 | 0.170 |
Why?
|
| Probiotics | 1 | 2023 | 229 | 0.170 |
Why?
|
| Policy Making | 1 | 2020 | 62 | 0.170 |
Why?
|
| Codeine | 1 | 2020 | 23 | 0.170 |
Why?
|
| Organizational Policy | 1 | 2020 | 54 | 0.170 |
Why?
|
| Oxygen | 1 | 2024 | 576 | 0.170 |
Why?
|
| Cholestasis | 1 | 2022 | 157 | 0.170 |
Why?
|
| Echoencephalography | 1 | 2020 | 26 | 0.160 |
Why?
|
| Seeds | 1 | 2020 | 43 | 0.160 |
Why?
|
| Morphine | 1 | 2020 | 87 | 0.160 |
Why?
|
| Registries | 2 | 2025 | 1591 | 0.160 |
Why?
|
| Drug Evaluation | 1 | 2019 | 105 | 0.160 |
Why?
|
| Kangaroo-Mother Care Method | 1 | 2019 | 3 | 0.160 |
Why?
|
| Stress, Psychological | 1 | 2025 | 605 | 0.160 |
Why?
|
| Rhombencephalon | 2 | 2009 | 50 | 0.160 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 147 | 0.160 |
Why?
|
| Cohort Studies | 4 | 2025 | 5205 | 0.160 |
Why?
|
| Manikins | 1 | 2020 | 138 | 0.150 |
Why?
|
| Patient Care Bundles | 1 | 2019 | 26 | 0.150 |
Why?
|
| Pregnancy, Multiple | 1 | 2019 | 48 | 0.150 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2020 | 178 | 0.150 |
Why?
|
| Blood Transfusion | 1 | 2020 | 296 | 0.150 |
Why?
|
| Blood Gas Analysis | 1 | 2018 | 85 | 0.140 |
Why?
|
| Child, Preschool | 6 | 2024 | 14904 | 0.140 |
Why?
|
| Food, Fortified | 1 | 2018 | 99 | 0.140 |
Why?
|
| Eating | 1 | 2020 | 392 | 0.140 |
Why?
|
| Administration, Inhalation | 1 | 2018 | 182 | 0.140 |
Why?
|
| Eye Diseases | 1 | 2019 | 118 | 0.140 |
Why?
|
| Pulmonary Surfactants | 1 | 2018 | 45 | 0.140 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 291 | 0.140 |
Why?
|
| Phospholipids | 1 | 2018 | 108 | 0.130 |
Why?
|
| Double-Blind Method | 4 | 2022 | 1654 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2020 | 375 | 0.130 |
Why?
|
| Hospitals | 1 | 2020 | 442 | 0.130 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 269 | 0.130 |
Why?
|
| Infant Mortality | 1 | 2018 | 180 | 0.130 |
Why?
|
| Antiviral Agents | 1 | 2022 | 826 | 0.130 |
Why?
|
| Brain Injuries | 1 | 2022 | 717 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 423 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 1159 | 0.120 |
Why?
|
| Biological Products | 1 | 2018 | 139 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 342 | 0.120 |
Why?
|
| Informed Consent | 1 | 2018 | 344 | 0.120 |
Why?
|
| Child | 4 | 2024 | 25888 | 0.110 |
Why?
|
| Liver | 1 | 2002 | 1845 | 0.110 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 677 | 0.110 |
Why?
|
| Glucose | 1 | 2019 | 907 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1613 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2021 | 554 | 0.110 |
Why?
|
| Logistic Models | 1 | 2019 | 1870 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 1173 | 0.110 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 550 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1256 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 1354 | 0.110 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 803 | 0.100 |
Why?
|
| Hospitalization | 1 | 2022 | 1912 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2019 | 727 | 0.100 |
Why?
|
| Epilepsy | 1 | 2021 | 899 | 0.100 |
Why?
|
| Biomarkers | 2 | 2020 | 3417 | 0.090 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3450 | 0.090 |
Why?
|
| Pakistan | 1 | 2011 | 95 | 0.090 |
Why?
|
| Proprioception | 1 | 2009 | 20 | 0.080 |
Why?
|
| Periodicity | 1 | 2009 | 52 | 0.080 |
Why?
|
| Arousal | 1 | 2009 | 82 | 0.080 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 1888 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2009 | 77 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3097 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13101 | 0.080 |
Why?
|
| Adult | 3 | 2025 | 31787 | 0.080 |
Why?
|
| Time Factors | 1 | 2018 | 6545 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2008 | 215 | 0.070 |
Why?
|
| Recurrence | 1 | 2011 | 1470 | 0.070 |
Why?
|
| Interneurons | 1 | 2008 | 147 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2008 | 275 | 0.070 |
Why?
|
| Risk Factors | 3 | 2022 | 10970 | 0.070 |
Why?
|
| Brain | 3 | 2024 | 3220 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2021 | 1251 | 0.060 |
Why?
|
| Mother-Child Relations | 1 | 2025 | 80 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 6586 | 0.050 |
Why?
|
| Stem Cells | 1 | 2008 | 748 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2024 | 295 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2025 | 231 | 0.050 |
Why?
|
| Asphyxia | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hemochromatosis Protein | 1 | 2002 | 23 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2009 | 3978 | 0.050 |
Why?
|
| Hepcidins | 1 | 2002 | 27 | 0.050 |
Why?
|
| Neurons | 2 | 2009 | 2050 | 0.050 |
Why?
|
| Olive Oil | 1 | 2022 | 24 | 0.050 |
Why?
|
| Indomethacin | 1 | 2022 | 81 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 96 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2022 | 71 | 0.050 |
Why?
|
| Fish Oils | 1 | 2022 | 83 | 0.050 |
Why?
|
| Albuminuria | 1 | 2022 | 115 | 0.050 |
Why?
|
| Bilirubin | 1 | 2022 | 131 | 0.050 |
Why?
|
| Spleen | 1 | 2002 | 286 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3869 | 0.040 |
Why?
|
| Hydrops Fetalis | 1 | 2021 | 84 | 0.040 |
Why?
|
| Patient Safety | 1 | 2025 | 437 | 0.040 |
Why?
|
| Trust | 1 | 2021 | 82 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5453 | 0.040 |
Why?
|
| Administration, Buccal | 1 | 2019 | 5 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 277 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 67 | 0.040 |
Why?
|
| Triglycerides | 1 | 2022 | 615 | 0.040 |
Why?
|
| Iron | 1 | 2022 | 303 | 0.040 |
Why?
|
| Pacifiers | 1 | 2019 | 5 | 0.040 |
Why?
|
| Bevacizumab | 1 | 2019 | 80 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 76 | 0.040 |
Why?
|
| Glutamic Acid | 2 | 2009 | 209 | 0.040 |
Why?
|
| Steroids | 1 | 2019 | 210 | 0.040 |
Why?
|
| Acute Disease | 1 | 2021 | 1185 | 0.040 |
Why?
|
| Vomiting | 1 | 2018 | 110 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2018 | 457 | 0.030 |
Why?
|
| Acidosis | 1 | 2018 | 101 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2019 | 225 | 0.030 |
Why?
|
| Laser Therapy | 1 | 2019 | 227 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 520 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2023 | 774 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2018 | 596 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2020 | 1717 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2021 | 1253 | 0.030 |
Why?
|
| Mice | 4 | 2009 | 18910 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 360 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2019 | 400 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2880 | 0.030 |
Why?
|
| Retina | 1 | 2019 | 495 | 0.030 |
Why?
|
| Cell Movement | 2 | 2009 | 907 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2020 | 981 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2009 | 2520 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 36122 | 0.020 |
Why?
|
| Hypoventilation | 1 | 2009 | 12 | 0.020 |
Why?
|
| Auditory Pathways | 1 | 2009 | 20 | 0.020 |
Why?
|
| Medulla Oblongata | 1 | 2009 | 23 | 0.020 |
Why?
|
| Somatostatin | 1 | 2009 | 69 | 0.020 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 58 | 0.020 |
Why?
|
| Auditory Perception | 1 | 2009 | 41 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2009 | 85 | 0.020 |
Why?
|
| Levodopa | 1 | 2009 | 94 | 0.020 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2008 | 42 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 402 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 958 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2008 | 479 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2009 | 283 | 0.020 |
Why?
|
| Neurogenesis | 1 | 2009 | 223 | 0.020 |
Why?
|
| Nerve Net | 1 | 2009 | 264 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 586 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 1049 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2008 | 2720 | 0.010 |
Why?
|